Loading articles...
Patients with early-onset Alzheimer's dementia (EOAD) may present with distinct comorbidity patterns compared to those with genetic mutations. The question becomes whether these differences warrant tailored screening protocols to improve outcomes and manage...
Alzheimer's disease may drive systemic comorbidities directly through neuropathological changes, not simply as a consequence of aging. This shift suggests future therapies should target the core pathology to address multiple organ systems.